Federica Messina

Dr. Federica Messina


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
FTFabrizio Termite
Fabrizio Termite
LGLinda Galasso
Linda Galasso
Giacomo CapeceGiacomo Capece
Giacomo Capece
FMFederica Messina
Federica Messina
GEGiorgio Esposto
Giorgio Esposto
MZMaria Assunta Zocco
Maria Assunta Zocco
Soft tissue tumors (STTs) are a heterogeneous group of mesenchymal neoplasms requiring accurate differentiation for optimal patient management. While histopathology remains the gold standard, imaging plays a crucial role in non-invasive assessment. Multiparametric ultrasound (mpUS) has emerged as a promising, cost-effective alternative to MRI, integrating B-mode, color and power Doppler, shear wave elastography (SWE), and contrast-enhanced ultrasound (CEUS) to provide comprehensive morphological, vascular, and biomechanical insights. Each modality offers distinct yet complementary diagnostic value, enhancing accuracy and potentially reducing unnecessary biopsies. This narrative review aims to serve as a practical guide, providing a readily accessible reference for mpUS parameters useful in the differential diagnosis of soft tissue tumors.

29 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FMFederica Messina
Federica Messina
CMCesare Meschini
Cesare Meschini
MOMaria Serena Oliva
Maria Serena Oliva
MCMatteo Caredda
Matteo Caredda
ABAntonio Bove
Antonio Bove
AZAntonio Ziranu
Antonio Ziranu
Background: Megaprosthetic replacement is widely used following tumour resection but remains challenged by periprosthetic joint infection (PJI) and variable functional outcomes. This narrative review aims to summarise current evidence on infection rates, prevention strategies, and functional outcomes following proximal humerus megaprosthetic reconstruction. We hypothesise that antibacterial coatings and improved soft-tissue techniques reduce infection rates and enhance functional recovery. Methods: A comprehensive narrative review of PubMed, Web of Science, and the Cochrane Library was performed using the terms proximal humerus, shoulder, bone tumor, sarcoma, neoplasm, infection, megaprosthesis, and endoprosthetic replacement. Reference lists were screened manually. Case reports and series with fewer than five patients were excluded. Twenty-seven clinical studies (more than 1100 patients; mainly osteosarcoma, chondrosarcoma, and metastatic lesions) were included and qualitatively analyzed. Results: The reported infection rates ranged from 4% to 20%, with higher risk in patients receiving adjuvant therapy. Silver-coated implants reduced PJI compared with uncoated designs (e.g., 11.2% → 9.2% in primary implants; 29.2% → 13.7% in revisions) without systemic toxicity. Alternative antibacterial coatings (e.g., silver- or copper-enriched hydroxyapatite) showed promising early results but remain supported by limited clinical data. Soft-tissue stabilization with Trevira tube or synthetic mesh improved joint stability and did not increase infection risk. Functional outcomes, usually assessed by MSTS or TESS, were moderate to good (≈60–80%) overall, with better scores when the deltoid and axillary nerve were preserved or when reverse total shoulder arthroplasty was possible. Conclusions: Proximal humerus megaprosthetic reconstruction benefits from meticulous soft-tissue handling, selective use of antibacterial technologies, and multidisciplinary management. The current literature is mainly retrospective, heterogeneous, and non-comparative. Prospective multicenter studies are needed to clarify the long-term effectiveness of silver or alternative coatings, soft-tissue reconstruction techniques, and emerging custom-made 3D-printed prostheses.

8 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FMFederica Messina
Federica Messina
AZAntonio Ziranu
Antonio Ziranu
DCDonato Coppola
Donato Coppola
MDMario Di Diego
Mario Di Diego
Giacomo CapeceGiacomo Capece
Giacomo Capece
RVRaffaele Vitiello
Raffaele Vitiello
Background: Soft tissue tumors (STTs) represent a heterogeneous group of rare lesions that frequently mimic bone sarcomas in both clinical and radiologic appearance. Accurate differentiation between benign and malignant lesions is critical for appropriate treatment planning, yet conventional imaging often remains inconclusive. Ultrasound (US) elastography, a non-invasive method that quantifies tissue stiffness, has recently emerged as a potential adjunct to standard musculoskeletal imaging for improving diagnostic confidence and guiding biopsy. Methods: A systematic review was conducted in accordance with PRISMA guidelines. PubMed, Web of Science, and Cochrane Library were searched using the keywords “elastography”, “sonoelastography”, and “soft tissue tumor”. Twelve studies encompassing 1554 patients met the inclusion criteria, assessing the diagnostic accuracy of strain, compression, and shear wave elastography for differentiating benign from malignant STTs. Results: Elastography alone demonstrated limited specificity when used as a single diagnostic technique. However, its integration into multiparametric ultrasound approaches—combining grayscale, Doppler, and contrast-enhanced imaging—significantly improved diagnostic performance. Several studies reported sensitivities and specificities exceeding 85% when elastographic parameters were incorporated into composite diagnostic scores. Conclusions: Ultrasound elastography shows promise as a quantitative imaging biomarker for the preoperative evaluation of musculoskeletal tumors, particularly in distinguishing soft tissue from bone-related lesions. Although not a substitute for histopathological confirmation, its application within multimodal ultrasound protocols may reduce unnecessary biopsies, enhance diagnostic accuracy, and facilitate tailored management of bone and soft tissue sarcomas.

18 June 2026 in Diseases
Verified
Journal Article
Open access
PDF file
GRGiuseppe Rovere
Giuseppe Rovere
FMFederica Messina
Federica Messina
CMCesare Meschini
Cesare Meschini
MOMaria Serena Oliva
Maria Serena Oliva
MCMatteo Caredda
Matteo Caredda
AZAntonio Ziranu
Antonio Ziranu
Background: Pathological fractures of the humerus secondary to metastatic disease represent a significant cause of pain, disability, and reduced quality of life in oncologic patients. Surgical management aims to restore stability, reduce pain, and allow early mobilization. However, the optimal strategy between intramedullary nailing and modular megaprosthesis remains debated, particularly in relation to functional outcomes and long-term results. Methods: A retrospective observational study was conducted on 48 patients treated for pathological or impending humeral fractures between January 2015 and January 2025. Twenty-six patients underwent intramedullary nailing (IMN group), while twenty-two were treated with tumor resection and modular megaprosthesis reconstruction (MP group). Functional outcomes were assessed using the Musculoskeletal Tumor Society (MSTS) score, Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH), and Western Ontario Shoulder Instability Index (WOSI) at 1, 12, 24, 36, and 60 months, and at 10 years. Complications and overall survival were also analyzed. Results: Intramedullary nailing demonstrated significantly superior early functional outcomes, with higher MSTS scores at 1 month (78% vs. 63%, p < 0.001) and lower QuickDASH scores in the first 24 months (p = 0.002). WOSI scores also favored IMN in the early postoperative period (p = 0.004). Megaprosthesis showed a slower initial recovery but a progressive improvement over time, reaching comparable functional outcomes at long-term follow-up (p > 0.05). The overall complication rate was similar between groups (p = 0.28), although periprosthetic infections occurred only in the MP group. Survival analysis did not show significant differences between groups (p = 0.74). Conclusions: Both intramedullary nailing and modular megaprosthesis represent effective surgical options for pathological and impending humeral fractures. Intramedullary nailing provides faster early functional recovery, whereas megaprosthetic reconstruction offers a durable reconstructive solution for extensive proximal lesions. Functional outcomes progressively converged between the two techniques approximately 2–3 years after surgery. Mid-term outcomes up to five years appeared comparable, suggesting that surgical decision-making should be individualized according to lesion characteristics, tumor biology, expected survival, and functional demands.